Indaptus Therapeutics, Inc. (INDP)
INDP Stock Price Chart
Explore Indaptus Therapeutics, Inc. interactive price chart. Choose custom timeframes to analyze INDP price movements and trends.
INDP Company Profile
Discover essential business fundamentals and corporate details for Indaptus Therapeutics, Inc. (INDP) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
4 Aug 2015
Employees
5.00
Website
https://indaptusrx.comCEO
Junyi Dai
Description
Indaptus Therapeutics, Inc. is a biotechnology company operating in the pre-clinical phase, dedicated to developing a range of immunotherapeutic products for the treatment of both cancer and viral infections. The firm's lead investigational compound, Decoy20, is currently progressing through Phase I clinical trials. This candidate is being evaluated for its capacity to elicit lasting therapeutic responses, either as a standalone agent or in combination with other treatments, for various conditions including lymphoma, hepatocellular, colorectal, and pancreatic tumors, as well as infections caused by the hepatitis B virus and human immunodeficiency virus. Initially incorporated in 2021 under the name Intec Parent, Inc., the company officially rebranded to Indaptus Therapeutics, Inc. in August of the same year. Its corporate headquarters are situated in New York, New York.
INDP Financial Timeline
Browse a chronological timeline of Indaptus Therapeutics, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 17 Aug 2026
EPS estimate is -$1.57.
Earnings released on 15 May 2026
EPS came in at -$0.23 surpassing the estimated -$1.87 by +87.70%.
Earnings released on 17 Mar 2026
EPS came in at -$3.10 surpassing the estimated -$4.36 by +28.90%.
Earnings released on 12 Nov 2025
EPS came in at -$2.98 surpassing the estimated -$4.17 by +28.54%.
Earnings released on 13 Aug 2025
EPS came in at -$9.09 surpassing the estimated -$9.24 by +1.62%.
Stock split effective on 27 Jun 2025
Shares were split 1 : 28 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 14 May 2025
EPS came in at -$8.96 surpassing the estimated -$11.48 by +21.95%.
Earnings released on 13 Mar 2025
EPS came in at -$0.38 surpassing the estimated -$0.41 by +7.32%.
Earnings released on 12 Nov 2024
EPS came in at -$0.32 surpassing the estimated -$0.47 by +31.91%.
Earnings released on 12 Aug 2024
EPS came in at -$0.47 surpassing the estimated -$0.54 by +12.96%.
Earnings released on 8 May 2024
EPS came in at -$0.45 surpassing the estimated -$0.57 by +21.05%.
Earnings released on 13 Mar 2024
EPS came in at -$0.47 surpassing the estimated -$0.54 by +12.96%, while revenue for the quarter reached $1.93k .
Earnings released on 6 Nov 2023
EPS came in at -$0.47 surpassing the estimated -$0.55 by +14.55%.
Earnings released on 14 Aug 2023
EPS came in at -$0.39 surpassing the estimated -$0.58 by +32.76%.
Earnings released on 11 May 2023
EPS came in at -$0.51 surpassing the estimated -$0.59 by +13.56%.
Earnings released on 17 Mar 2023
EPS came in at -$0.44 surpassing the estimated -$0.52 by +15.38%.
Earnings released on 10 Nov 2022
EPS came in at -$0.42 surpassing the estimated -$0.47 by +10.64%.
Earnings released on 8 Aug 2022
EPS came in at -$0.46 falling short of the estimated -$0.43 by -6.98%.
Earnings released on 12 May 2022
EPS came in at -$0.41 falling short of the estimated -$0.39 by -5.13%.
Earnings released on 21 Mar 2022
EPS came in at -$0.22 surpassing the estimated -$0.90 by +75.56%.
Earnings released on 15 Nov 2021
EPS came in at -$0.81 falling short of the estimated -$0.55 by -47.27%.
Earnings released on 16 Aug 2021
EPS came in at -$5.53 falling short of the estimated -$2.56 by -116.02%.
Stock split effective on 27 Jul 2021
Shares were split 1 : 4 , changing the number of shares outstanding and the price per share accordingly.
INDP Stock Performance
Access detailed INDP performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
